Ignite Creation Date:
2024-05-06 @ 2:03 AM
Last Modification Date:
2024-10-26 @ 11:13 AM
Study NCT ID:
NCT01957592
Status:
WITHDRAWN
Last Update Posted:
2014-10-02
First Post:
2013-10-01
Brief Title:
A Cross-Sectional Survey to Evaluate Diabetes Management Control Complications Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka
Sponsor:
Novo Nordisk AS
Organization:
Novo Nordisk AS
Study Overview
Official Title:
A Cross-Sectional Survey to Evaluate Diabetes Management Control Complications Psychosocial Aspects of Patients With Type 2 Diabetes in Sri Lanka
Status:
WITHDRAWN
Status Verified Date:
2014-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
DiabCare Asia
Brief Summary:
This study is conducted in Asia The aim of this non-interventional study is to evaluate the current status of diabetes management control and complications in diabetic subjects in Sri Lanka
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| U1111-1138-8495 | OTHER | WHO | None |